IRIS
PEROSA, Federico
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 12.535
EU - Europa 5.299
AS - Asia 4.951
SA - Sud America 1.388
Continente sconosciuto - Info sul continente non disponibili 441
AF - Africa 193
OC - Oceania 19
Totale 24.826
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 12.176
SG - Singapore 2.114
IT - Italia 1.807
BR - Brasile 1.090
CN - Cina 1.090
RU - Federazione Russa 1.059
HK - Hong Kong 649
SE - Svezia 531
DE - Germania 403
UA - Ucraina 394
VN - Vietnam 312
FI - Finlandia 304
FR - Francia 296
GB - Regno Unito 239
BD - Bangladesh 159
IN - India 150
CA - Canada 145
AR - Argentina 109
ID - Indonesia 72
IQ - Iraq 62
TR - Turchia 62
EC - Ecuador 56
MX - Messico 48
CO - Colombia 40
PL - Polonia 40
ZA - Sudafrica 40
JP - Giappone 39
IE - Irlanda 35
NL - Olanda 33
UZ - Uzbekistan 32
CR - Costa Rica 31
PK - Pakistan 30
SA - Arabia Saudita 30
BE - Belgio 29
CI - Costa d'Avorio 29
MA - Marocco 28
ES - Italia 27
CL - Cile 25
PH - Filippine 25
AT - Austria 24
VE - Venezuela 24
JO - Giordania 19
TN - Tunisia 19
CW - ???statistics.table.value.countryCode.CW??? 18
PY - Paraguay 17
SV - El Salvador 17
GT - Guatemala 16
JM - Giamaica 16
KE - Kenya 16
AU - Australia 15
MY - Malesia 15
PR - Porto Rico 15
TT - Trinidad e Tobago 14
GP - Guadalupe 13
EG - Egitto 12
HN - Honduras 12
PE - Perù 12
AZ - Azerbaigian 11
DO - Repubblica Dominicana 11
DZ - Algeria 11
IR - Iran 11
LT - Lituania 10
RO - Romania 10
HR - Croazia 9
NI - Nicaragua 9
PS - Palestinian Territory 9
AL - Albania 8
EU - Europa 7
UY - Uruguay 7
BO - Bolivia 6
NP - Nepal 6
PA - Panama 6
AE - Emirati Arabi Uniti 5
CH - Svizzera 5
KG - Kirghizistan 5
RS - Serbia 5
TH - Thailandia 5
AO - Angola 4
ET - Etiopia 4
IL - Israele 4
KR - Corea 4
LB - Libano 4
MD - Moldavia 4
MK - Macedonia 4
NG - Nigeria 4
NZ - Nuova Zelanda 4
SN - Senegal 4
SY - Repubblica araba siriana 4
AM - Armenia 3
BB - Barbados 3
CZ - Repubblica Ceca 3
DK - Danimarca 3
EE - Estonia 3
GE - Georgia 3
OM - Oman 3
PT - Portogallo 3
TG - Togo 3
BA - Bosnia-Erzegovina 2
BY - Bielorussia 2
BZ - Belize 2
Totale 24.367
Salva come PNG Salva come JPEG
Città #
Ashburn 1.420
Singapore 1.137
Chandler 927
Jacksonville 916
San Jose 915
Fairfield 859
Woodbridge 663
Hong Kong 642
Milan 596
Houston 514
Ann Arbor 396
Nyköping 377
Seattle 360
Cambridge 354
Wilmington 325
Bari 320
Beijing 290
Council Bluffs 283
Rome 237
New York 203
Lawrence 201
Roxbury 200
Nanjing 196
Lauterbourg 191
Los Angeles 154
Boardman 144
Des Moines 133
Helsinki 110
Dallas 107
Santa Clara 104
São Paulo 103
Columbus 98
Ho Chi Minh City 97
Princeton 91
Hanoi 69
Brooklyn 67
Inglewood 67
Buffalo 63
Phoenix 56
Nanchang 55
Chicago 53
Shenyang 50
London 49
Hebei 47
Moscow 42
San Diego 42
Figino 41
Rio de Janeiro 41
Montreal 40
Toronto 39
Tokyo 38
Munich 37
Pune 37
Turin 37
Falkenstein 35
Atlanta 33
Orem 33
Jiaxing 32
Jakarta 30
Abidjan 29
Dublin 28
Frankfurt am Main 28
Tashkent 28
Tianjin 28
Brussels 27
Belo Horizonte 26
Changsha 26
Naples 26
Paris 25
Denver 24
Warsaw 24
Guangzhou 23
Quito 23
Chennai 22
Curitiba 22
Stockholm 22
Amsterdam 21
Baghdad 21
Bologna 21
Dhaka 21
Nuremberg 21
Washington 21
San Francisco 20
San José 20
Boston 19
Noicattaro 19
Brasília 18
Johannesburg 18
Porto Alegre 18
Willemstad 18
Amman 17
Guayaquil 17
Haiphong 17
Poplar 17
Dong Ket 16
Guatemala City 16
Medellín 16
Campinas 15
Dearborn 15
Marseille 15
Totale 15.664
Salva come PNG Salva come JPEG
Nome #
Response to "Is active acid sphingomyelinase required for the antiproliferative response to rituximab?" [e-letter]. http://bloodjournal.hematologylibrary.org/content/117/13/3695.citation/reply#bloodjournal_el_2268 777
Anti-carbamylated protein antibodies and skin involvement in patients with systemic sclerosis: An intriguing association 232
CD20-Mimotope Peptides: A Model to Define the Molecular Basis of Epitope Spreading 203
Clinical correlates of human leucocyte antigen (HLA)-G in systemic sclerosis 194
Autoantibodies Recognizing the Amino Terminal 1-17 Segment of CENP-A Display Unique Specificities in Systemic Sclerosis 186
Anti-centromere protein A antibodies in systemic sclerosis: Significance and origin 186
Antibody V(h) repertoire differences between resolving and chronically evolving hepatitis C virus infections 181
CD20-Mimotope Peptide Active Immunotherapy in Systemic Lupus Erythematosus and a Reappraisal of Vaccination Strategies in Rheumatic Diseases 178
MHC Class i Antigen Processing and Presenting Machinery: Organization, Function, and Defects in Tumor Cells 177
Autoantibodies to intracellular antigens: generation and pathogenetic role 177
Evaluation of the influence of social, demographic, environmental, work-related factors and/or lifestyle habits on Raynaud's phenomenon: a case-control study 175
CD20-depleting therapy in autoimmune diseases: from basic research to the clinic 174
Oxidized low density lipoproteins: The bridge between atherosclerosis and autoimmunity. Possible implications in accelerated atherosclerosis and for immune intervention in autoimmune rheumatic disorders. 174
Alterations in the antigen processing-presenting machinery of transformed plasma cells are associated with reduced recognition by CD8+ T cells and characterize the progression of MGUS to multiple myeloma 172
Alternative splicing of HLA-C mRNA in HCV-infected hepatocytes reduces viral epitope-specific cytotoxicity T cell response and promotes NK activity 171
Subspecificities of anticentromeric protein A antibodies identify systemic sclerosis patients at higher risk of pulmonary vascular disease 164
AB0695 Subspecificities of Anti-Centromeric-Associated Protein a (CENP-A) Antibodies (AB) Can Identified a Subset of Patients at Higher Risk of Developing Pulmonary Hypertension 163
Severe pulmonary hypertension as the initial manifestation of systemic lupus erythematosus: a case report and review of the literature 155
B-T cell interaction in the pathogenesis of HCV-positive mixed cryoglobulinemia. 154
Clinical correlates of a subset of anti-CENP-A antibodies cross-reacting with FOXE3p53-62 in systemic sclerosis 153
CD20 mimicry by a mAb rituximab-specific linear peptide: A potential tool for active immunotherapy of autoimmune diseases 153
Working and safety profiles of JAK/STAT signaling inhibitors. Are these small molecules also smart? 152
Antiphospholipids syndrome complicated by a systemic capillary leak-like syndrome treated with steroids and intravenous immunoglobulins a case report 152
Absence of streptococcal protein G (PG)-specific determinant in the Fab region of human IgG2 149
Rheumatic disorders as paraneoplastic syndromes 147
Serum levels of beta-2-microglobulin-free heavy chain of HLA class I antigen in healthy individuals: relationship to their class I allotype 146
Vasculitides: Proposal for an integrated nomenclature 146
Alterations in the antigen processing-presenting machinery of transformed plasma cells are associated with reduced recognition by CD8+ T cells and characterize the progression of MGUS to multiple myeloma 145
Effects of Adjuvants for Human Use in Systemic Lupus Erythematosus (Sle)-Prone (Nzb/Nzw) F1 Mice 144
CD20: A target antigen for immunotherapy of autoimmune diseases 142
Immunogenicity of two idiotypes with a different immunoglobulin-chain distribution expressed on the same anti-CD4 Mab 142
Extra-articular manifestations of rheumatoid arthritis: an update 141
Serological methods to detect anti-idiotypic antibodies 140
Uso di un anticorpo monoclonale antiidiotipo di un anticorpo monoclonale anti-CD4 in pazienti con artrite reumatoide 139
Amyloidosis: clinical picture, immunological and biomolecular features, treatment prospects 139
Bortezomib-thalidomide-dexamethasone is superior to thalidomide-dexamethasone as consolidation therapy after autologous hematopoietic stem cell transplantation in patients with newly diagnosed multiple myeloma 139
A sandwich assay to detect and characterize syngeneic anti-idiotypic antibodies to murine anti-HLA and tumor associated antigen monoclonal antibodies 139
Anti-carbamylated protein antibodies in patients with systemic sclerosis: an intriguing association with skin involvement 139
Amyloidosis: clinical picture, immunological and biomolecular features, treatment prospects 138
Human CD4 internal antigen anti-idiotypic monoclonal antibody. Immunochemical and sequence analysis 138
Analisi molecolare di un anticorpo monoclonale (ACMO) anti-idiotipo 'immagine interna' dell'antigene CD4 138
Beta-2 microglobulin-free HLA class I heavy chain (FHC) A3 and/or A30 soluble products contribute only minimally to serum FHC expression 138
The proliferative transcriptional factor FOXE3 is the target of anti-CENP-A antibodies and identifies a subset of anti-CENP antibody positive systemic sclerosis patients 137
Generation of biologically active linear and cyclic peptides has revealed a unique fine specificity of rituximab and its possible cross-reactivity with acid sphingomyelinase-like phosphodiesterase 3b precursor 137
Biological therapy with monoclonal antibodies: a novel treatment approach to autoimmune disease 136
Subclinical and clinical atherosclerosis in rheumatoid arthritis: Results from the 3-year, multicentre, prospective, observational GIRRCS (Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale) study 134
Identification of an antigenic and immunogenic motif expressed by two 7-Mer Rituximab-specific cyclic peptides 130
CD20 mimicry by mAb Rituximab-specific linear peptide. A potential tool for active immunotherapy of autoimmune diseases 130
International consensus: What else can we do to improve diagnosis and therapeutic strategies in patients affected by autoimmune rheumatic diseases (rheumatoid arthritis, spondyloarthritides, systemic sclerosis, systemic lupus erythematosus, antiphospholipid syndrome and Sjogren's syndrome)?: The unmet needs and the clinical grey zone in autoimmune disease management 129
The Fab region of IgG2 human myeloma proteins does not bear the streptococcal protein G-specific determinant 129
Endothelial cells in tumor microenvironment: insights and perspectives 127
L'AMILOIDOSI: QUADRI CLINICI, CARATTERISTICHE IMMUNOLOGICHE E BIOMOLECOLARI, PROSPETTIVE TERAPEUTICHE 127
Guidelines for biomarkers in autoimmune rheumatic diseases - evidence based analysis 127
SARS-CoV-2 infection complicated by inflammatory syndrome. Could high-dose human immunoglobulin for intravenous use (IVIG) be beneficial? 127
Sars-cov-2 inflammatory syndrome. Clinical features and rationale for immunological treatment 127
Beta2-microglobulin-free HLA class I heavy chain epitope mimicry by monoclonal antibody HC-10-specific peptide 126
Preparation, characterization and utilization of monoclonal antibodies to the gene products of the HLA-D region with special emphasis on those to polymorphic determinants 124
Analysis of beta-2 microglobulin (b2M), free HLA class I heavy chain (FHC) and the associated protein pattern in multiple myeloma (MM) patients from the Nordic Myeloma Group Study #5/94. Haematologica-the Hematology Journal 124
Two structurally different rituximab-specific CD20 mimotope peptides reveal that rituximab recognizes two different CD20-associated epitopes 123
Increased serum levels of beta2m-free HLA class I heavy chain in multiple myeloma 123
Cinetica di produzione e clonotipia di anticorpi anti-anti-idiotipo (Ac3) in due pazienti affette da patologia autoimmune immunizzate con un anticorpo monoclonale anti-idiotipo (AcMo2) 122
Anti-idiotypic antibodies in therapy: current status and prospects 121
Macrophage activation syndrome in patients affected by adult-onset still disease: Analysis of survival rates and predictive factors in the Gruppo Italiano di Ricerca in reumatologia clinica e sperimentale cohort 121
Personalized medicine in rheumatoid arthritis: How immunogenicity impacts use of TNF inhibitors 120
Anticorpi monoclonali nell'immunoterapia delle malattie autoimmuni 119
Low mortality rate in Italian rheumatoid arthritis patients from a tertiary center: Putative implication of a low anti-carbamylated protein antibodies prevalence 119
Mieloma multiplo e gammapatie monoclonali: quadri clinici, acquisizioni eziopatogenetiche e progressi terapeutici 116
The immunodominant epitope of centromere-associated protein A displays homology with the transcription factor forkhead box E3 (FOXE3) 116
Identification of an antigenic and immunogenic motif expressed by two 7-mer rituximab-specific cyclic peptide mimotopes: Implication for peptide-based active immunotherapy 115
Human anti-mouse antibodies interfere in the determination of sCD4 in intravenous immunoglobulin preparations 115
Vaccination against CD20 mimotope peptiide. Is it a feasible strategy for the treatment of autoimmune diseases? 114
Insight into the specificità of the anti-CD20 monclonal antibody Rituximab. 114
Analysis in a syngeneic and xenogeneic system of mouse antiidiotypic (Ab2) monoclonal antibodies (mAb) elicited with the syngeneic anti-CD4 mAb HP2/6 114
Evaluation of biotinylated cells as a source of antigens for characterization of their molecular profile 113
B2 microglobulin-free heavy chain (FHC) of HLA class I antigen in patients with Hodgkin’s and non Hodgkin’s lymphomas 112
Syngeneic polyclonal and monoclonal antiidiotypic antibodies to murine anti-human high molecular weight-melanoma associated antigen and anti-HLA monoclonal antibodies 112
Syngeneic antiidiotypic monoclonal antibodies to the murine anti-HLA- DR,DP monoclonal antibody CR11-462 111
Size variants of beta-2-microglobulin-free human leucocyte antigen class I heavy chain make different contributions to its serum increase in multiple myeloma 111
Antigenic mimicry by linear peptides of the conformational epitope recognized by the anti-CD20 monoclonal antibody (mAb) Rituximab 110
Analisi della risposta immune indotta da anticorpi monoclonali murini anti-idiotipo (Ab2) anti-CD4 in un sistema xenogenico 110
HLA allele prevalence in disease-modifying antirheumatic drugs-responsive enthesitis and/or arthritis not fulfilling ASAS criteria: Comparison with psoriatic and undifferentiated spondyloarthritis 109
Beta2-m-free heavy chain levels of HLA-class I antigen combined with serum IgM or platelet count provide two reliable staging systems in multiple myeloma 109
Mieloma multiplo e gammapatie monoclonali: quadri clinici, acquisizioni eziopatogenetiche e progressi terapeutici 109
Soluble CD4 antigen reactivity in intravenous immunoglobulin preparations: is it specific? 109
An 82-year-old woman with new onset of multiple purple-reddish nodules during treatment with abatacept for rheumatoid arthritis 108
Identificazione del peptide che mima l'epitopo localizzato sulla catena pesante HLA-I non associata alla beta 2-microglobulina, riconosciuto dall'anticorpo monoclonale HC-10 108
Characterization of the specificity of the Human scFv W9 108
Immunochemical and functional characterization of anti-idiotypic antibodies to a mouse anti-CD4 monoclonal antibody 108
Murine antiidiotypic monoclonal antibodies that bear the internal image of HLA-DR allospecificities 107
Staging multiple myeloma patients with active disease using serum levels of beta2m-free HLA class I heavy chain together with IgM or platelet count 107
Immunoterapia: realta' e fantasia 107
Purification of human immunoglobulins by sequential precipitation with caprylic acid and ammonium sulphate 107
Le vaccinazioni nei pazienti con immunodeficienza 106
EXPRESSION OF THE TRANSCRIPTION FACTOR FORKHEAD BOX E3 (FOXE3) IN PERIPHERAL BLOOD MONONUCLEAR CELLS OF PATIENTS WITH SYSTEMIC SCLEROSIS 105
Analisi della risposta immune indotta da anticorpi monoclonali murini anti-idiotipo (Ab2) anti-CD4 in un sistema xenogenico 105
Anti-idiotypic monoclonal antibodies (mAb) to an anti-CD4 mAb induce CD4+ T cell depletion in rabbit 105
Analisi molecolare di un anticorpo monoclonale (AcMo) anti-idiotipo “immagine interna” dell’antigene CD4 105
Anti-CD4 monoclonal antibody (mAb) and anti-idiotypic mAb to anti-CD4 in the therapy of autoimmune diseases 105
Anticorpi anti-DNA e network idiotipico nel LES: recenti progressi e prospettive terapeutiche 103
AUTO-ANTIBODIES TO THE AMINO TERMINAL SEGMENT (AMINOACID 1-17) OF CENP-A DISPLAY A UNIQUE SPECIFICITY IN SYSTEMIC SCLEROSIS AND ARE INDEPENDENTLY EXPRESSED FROM THOSE AGAINST CENP-B 103
Totale 14.047
Salva come PNG Salva come JPEG
Categoria #
all - tutte 100.849
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 100.849
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.135 0 0 0 80 77 70 110 86 63 42 236 371
2022/20232.316 340 204 114 226 323 333 36 264 361 28 52 35
2023/2024856 63 140 43 91 65 221 25 66 6 16 39 81
2024/20253.228 99 48 332 77 68 260 249 281 105 155 479 1.075
2025/20268.084 971 270 398 824 756 414 999 225 1.310 668 200 1.049
2026/20272.462 218 381 699 1.164 0 0 0 0 0 0 0 0
Totale 24.826